These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 2242362)

  • 1. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of endometriosis in women attending family planning clinics.
    Vessey MP; Villard-Mackintosh L; Painter R
    BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility following ectopic pregnancy with special reference to previous use of an intra-uterine contraceptive device (IUCD).
    Sandvei R; Ulstein M; Wollen AL
    Acta Obstet Gynecol Scand; 1987; 66(2):131-5. PubMed ID: 3618137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA; Aisien AO
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility after contraception or abortion.
    Huggins GR; Cullins VE
    Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA
    Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic inflammatory disease and the intrauterine device: findings in a large cohort study.
    Vessey MP; Yeates D; Flavel R; McPherson K
    Br Med J (Clin Res Ed); 1981 Mar; 282(6267):855-7. PubMed ID: 6783202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic inflammatory disease with intrauterine device use: a reassessment.
    Kessel E
    Fertil Steril; 1989 Jan; 51(1):1-11. PubMed ID: 2642807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to conception after IUD removal: importance of duration of use, IUD type, pelvic inflammatory disease and age.
    Andolsek L; Teeter RA; Kozuh-Novak M; Wheeler R; Fortney JA; Rosenberg MJ
    Int J Gynaecol Obstet; 1986 Jun; 24(3):217-23. PubMed ID: 2880761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
    Senanayake P; Kramer DG
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD; Kessel E
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract infection in relation to diaphragm use and obesity.
    Vessey MP; Metcalfe MA; McPherson K; Yeates D
    Int J Epidemiol; 1987 Sep; 16(3):441-4. PubMed ID: 3667045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of different contraceptive methods.
    Vessey M; Lawless M; Yeates D
    Lancet; 1982 Apr; 1(8276):841-2. PubMed ID: 6122067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.
    O'Brien FB; Stewart WC; Sturtevant FM
    Contraception; 1983 Feb; 27(2):111-22. PubMed ID: 6851553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.